• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿重症监护的新生儿风险因素及成本

Newborn risk factors and costs of neonatal intensive care.

作者信息

Phibbs C S, Williams R L, Phibbs R H

出版信息

Pediatrics. 1981 Sep;68(3):313-21.

PMID:6792583
Abstract

To understand the sources of the high costs of neonatal intensive care, financial and medical information on 1,185 admissions to an intensive care nursery was gathered. Multiple regression analysis showed that a significant portion of the variation in individual costs was explained by three measures of risk: low birth weight, surgical intervention, and assisted ventilation. There was a highly skewed distribution of costs. Nearly half of all admissions had none of the above risk factors, had an average cost of about $2,000, and accounted for only 13% of the total costs for the whole sample. In contrast, less than one quarter of the admissions had two or more of the risk factors, had an average cost of $19,800, and accounted for nearly 60% of the total costs. Models that predict costs and length of stay on a basis of seven risk factors were developed to allow for differences in patient populations.

摘要

为了解新生儿重症监护高成本的来源,收集了1185例入住重症监护病房的财务和医疗信息。多元回归分析表明,个体成本差异的很大一部分可由三个风险指标来解释:低出生体重、手术干预和辅助通气。成本分布严重不均衡。几乎一半的入院病例没有上述任何风险因素,平均成本约为2000美元,仅占整个样本总成本的13%。相比之下,不到四分之一的入院病例有两个或更多风险因素,平均成本为19800美元,占总成本的近60%。基于七个风险因素建立了预测成本和住院时间的模型,以考虑不同患者群体之间的差异。

相似文献

1
Newborn risk factors and costs of neonatal intensive care.新生儿重症监护的新生儿风险因素及成本
Pediatrics. 1981 Sep;68(3):313-21.
2
Costs of neonatal intensive care by day of stay.新生儿重症监护按住院天数计算的费用。
Inquiry. 1982 Summer;19(2):167-78.
3
Alternative to diagnosis-related groups for newborn intensive care.
Pediatrics. 1986 Nov;78(5):829-36.
4
Neonatal intensive care and cost effectiveness.新生儿重症监护与成本效益。
CMAJ. 1988 Nov 15;139(10):943-6.
5
[Calculating costs of premature infants' intensive care in the United States of America, Canada and Australia].[计算美国、加拿大和澳大利亚早产儿重症监护的成本]
Przegl Epidemiol. 2005;59(3):781-91.
6
Physician variations and the ancillary costs of neonatal intensive care.医生的差异与新生儿重症监护的辅助成本。
Health Serv Res. 1997 Aug;32(3):299-311.
7
Hospital costs for cocaine-exposed infants.可卡因暴露婴儿的住院费用。
J Fla Med Assoc. 1990 Oct;77(10):897-900.
8
Using economic information in a quality improvement collaborative.在质量改进协作中运用经济信息。
Pediatrics. 2003 Apr;111(4 Pt 2):e411-8.
9
[Costs of intensive care of premature infants].[早产儿重症监护的成本]
Przegl Epidemiol. 2006;60(1):155-62.
10
[Costs of the initial care of children with birth weight less than or equal to 1500 g in 1981].[1981年出生体重小于或等于1500克儿童的初始护理费用]
Arch Fr Pediatr. 1984 Oct;41(8):579-85.

引用本文的文献

1
Pre-cannulation lung biopsy shortens ECMO course.插管前肺活检可缩短体外膜肺氧合治疗时间。
Pediatr Surg Int. 2016 Jul;32(7):713-6. doi: 10.1007/s00383-016-3890-5. Epub 2016 Apr 16.
2
Data analysis of the benefits of an electronic registry of information in a neonatal intensive care unit in Greece.希腊一家新生儿重症监护病房信息电子登记系统效益的数据分析
Perspect Health Inf Manag. 2008 Jul 28;5:10.
3
Costs of newborn care in California: a population-based study.加利福尼亚州新生儿护理成本:一项基于人群的研究。
Pediatrics. 2006 Jan;117(1):154-60. doi: 10.1542/peds.2005-0484.
4
Surfactant replacement therapy--economic impact.表面活性剂替代疗法——经济影响。
Indian J Pediatr. 2001 Jun;68(6):501-5. doi: 10.1007/BF02723239.
5
Cost of neonatal intensive care.新生儿重症监护的费用。
Indian J Pediatr. 1998 Mar-Apr;65(2):249-55. doi: 10.1007/BF02752301.
6
Policy issues related to prospective payment for pediatric hospitalization.
Health Care Financ Rev. 1987 Fall;9(1):71-82.
7
Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.棕榈酸考福斯昔尔。对患有呼吸窘迫综合征的婴儿使用一种合成表面活性剂制剂(Exosurf Neonatal)的药物经济学评估。
Pharmacoeconomics. 1994 Dec;6(6):563-77. doi: 10.2165/00019053-199406060-00009.
8
Economic outcomes of colfosceril palmitate rescue therapy in infants weighing 1250g or more with respiratory distress syndrome: results from a randomised trial.
Pharmacoeconomics. 1994 Oct;6(4):358-69. doi: 10.2165/00019053-199406040-00003.
9
Cost effectiveness of beractant in the prevention of respiratory distress syndrome.
Pharmacoeconomics. 1993 Oct;4(4):278-86. doi: 10.2165/00019053-199304040-00006.
10
Cost effectiveness of surfactant replacement in preterm babies.
Pharmacoeconomics. 1993 May;3(5):362-73. doi: 10.2165/00019053-199303050-00004.